Robotti Robert’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,000
Closed -$17K 61
2025
Q4
$17K Hold
50,000
﹤0.01% 60
2025
Q3
$17.3K Hold
50,000
﹤0.01% 60
2025
Q2
$11K Hold
50,000
﹤0.01% 62
2025
Q1
$11.9K Hold
50,000
﹤0.01% 66
2024
Q4
$10.5K Hold
50,000
﹤0.01% 64
2024
Q3
$9.5K Hold
50,000
﹤0.01% 61
2024
Q2
$11.4K Hold
50,000
﹤0.01% 60
2024
Q1
$12.5K Hold
50,000
﹤0.01% 57
2023
Q4
$9.63K Hold
50,000
﹤0.01% 58
2023
Q3
$12.6K Hold
50,000
﹤0.01% 59
2023
Q2
$19.8K Hold
50,000
﹤0.01% 63
2023
Q1
$14K Hold
50,000
﹤0.01% 60
2022
Q4
$12.5K Sell
50,000
-50,000
-50% -$15.3K ﹤0.01% 64
2022
Q3
$45K Buy
100,000
+50,000
+100% +$29.5K 0.01% 67
2022
Q2
$24K Hold
50,000
0.01% 70
2022
Q1
$31K Buy
+50,000
New +$27.3K 0.01% 69

Other funds holding DRTSW

Robotti Robert's DRTSW Position: Q1 2026 in Review

Robotti Robert sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2026, closing a stake of 50,000 shares — an estimated $17K sold.

Robotti Robert first reported a position in DRTSW in Q1 2022 and held it in 16 quarters. The position peaked at $45K in Q3 2022. 21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

  • Robotti Robert reported no remaining Alpha Tau Medical Warrant position as of Q1 2026 after selling out during the quarter.
  • Robotti Robert sold 50,000 Alpha Tau Medical Warrant shares in Q1 2026, an estimated $17K.
  • Robotti Robert first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 16 quarters.
  • Robotti Robert's Alpha Tau Medical Warrant position peaked at $45K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on Robotti Robert's 13F filing for Q1 2026, filed 13 May 2026.